You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (73) |
Back to Search
Flucloxacillin induces liver injury in mice pretreated with a toll-like receptor 9 agonist in mitochondrial permeability transition dependent manner
- At: PSWC2020 (2020)
- Type: Poster
- By: ITO, Kousei (Chiba University, Graduate School of Pharmaceutical Sciences, Japan)
- Co-author(s): Yuying Gao: Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
Binbin Song: Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
Cong Liu: Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
Shigeki Aoki: Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan
Kousei Ito: Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan - Abstract:
Background
Flucloxacillin (FLUX) is one of the β-lactam antibiotics causing idiosyncratic liver injury in human, but its liver toxicity potential is hardly detectable in experimental animals.Purpose
FLUX and CpG-ODN (toll-like receptor 9 agonist) were co-administered to mice to reproduce early phase of FLUX-induced liver injury, and investigated.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026